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Abstract
Background: Ischaemic heart disease is a global priority of health-care policy, because of its social
repercussions and its impact on the health-care system. Yet there is little information on coronary
morbidity in Spain and on the effect of the principal risk factors on risk of coronary heart disease.
The objective of this study is to describe the epidemiology of coronary disease (incidence, mortality
and its association with cardiovascular risk factors) using the information gathered by primary care
practitioners on cardiovascular health of their population.
Methods:  A prospective study was designed. Eight primary-care centres participated, each
contributing to the constitution of the cohort with the entire population covered by the centre. A
total of 6124 men and women aged over 25 years and free of cardiovascular disease agreed to
participate and were thus enrolled and followed-up, with all fatal and non-fatal coronary disease
episodes being registered during a 5-year period. Repeated measurements were collected on
smoking, blood pressure, weight and height, serum total cholesterol, high-density and low-density
lipoproteins and fasting glucose. Rates were calculated for acute myocardial infarction and
ischaemic heart disease. Associations between cardiovascular risk factors and coronary disease-
free survival were evaluated using Kaplan-Meier and Cox regression analyses.
Results: Mean age at recruitment was 51.6 ± 15, with 24% of patients being over 65. At baseline,
74% of patients were overweight, serum cholesterol over 240 was present in 35% of patients,
arterial hypertension in 37%, and basal glucose over 126 in 11%. Thirty-four percent of men and
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13% of women were current smokers. During follow-up, 155 first episodes of coronary disease
were detected, which yielded age-adjusted rates of 362 and 191 per 100,000 person-years in men
and women respectively. Disease-free survival was associated with all risk factors in univariate
analyses. After multivariate adjustments, age, male gender, smoking, high total cholesterol, high
HDL/LDL ratio, diabetes and overweight remained strongly associated with risk. Relative risks for
hypertension in women and for diabetes in men did not reach statistical significance.
Conclusion: Despite high prevalence of vascular risk factors, incidence rates were lower than
those reported for other countries and other periods, but similar to those reported in the few
population-based studies in Spain. Effect measures of vascular risk factors were mainly as reported
worldwide and support the hypothesis that protective factors not considered in this study must
exist as to explain low rates. This study shows the feasibility of conducting epidemiological cohort
studies in primary-care settings.
Background
Ischaemic heart disease (IHD) is an extremely frequent
cause of hospitalisation and death in Spain. This has
made it a priority of health-care policy, not only because
of its social repercussions, but also because of its impact
on the health-care system [1]. Furthermore, incidence
studies conducted in Spain indicate that IHD is a frequent
disease, with rates in the order of 200 and 50 new myocar-
dial infarctions p.a. per 100,000 men and 100,000
women respectively [2-8]. At an international level, how-
ever, these rates are among the lowest in the world, not-
withstanding the fact that frequency of exposure to
cardiovascular risk factors is no less among Spaniards
than it is in other countries [9,10]. This phenomenon,
known as the French paradox, is also seen in other popu-
lations in the Mediterranean area and has been linked to
the possible existence of protective factors linked to the
Mediterranean diet [11-13]. Yet there is little information
on the effect of the principal risk factors on risk of coro-
nary heart disease in populations with low rates of IHD
morbidity and mortality [14,15]. Indeed, it has been pos-
tulated that the magnitude of the effect had by the princi-
pal cardiovascular risk factors on such populations might
be different to that had on populations registering high
rates [16].
In addition, the coronary morbidity information available
for Spain and for Europe in general, is sparse, only mar-
ginally comparable and subject to certain limitations
[8,15]. A recent review, ordered by the European Commis-
sion as part of the Health Monitoring Programme, con-
cluded that cardiovascular disease morbidity data are
rarely available in the different countries, and when avail-
able, are very rarely comparable [17]. Moreover, longitu-
dinal studies undertaken in Europe are already out of date
and their results on incidence cannot be extrapolated to
the present [15,18]. In Spain, neither the MONICA-Cata-
lonia study, nor the registers constituting the IBERICA
study, allow for the risk associated with exposure to risk
factors to be estimated [2-5]. Moreover, both studies
solely collect information on the incidence of acute myo-
cardial infarction and not on other forms of cardiac
ischaemia. The Manresa cohort study was confined to
men from a very restricted work setting, whereas, to date,
the DRECE study has not reported results on coronary
incidence by age and sex [6,7].
Primary-care settings, mostly in those health systems that
as the Spanish one cover the entire population, could be a
good alternative to population-based registries to conduct
epidemiological studies, as general practitioners are fully
qualified and capable for detecting both cardiovascular
risk of their patients and coronary events and deaths, and
moreover this information is routinely recorded in pri-
mary-care clinical practice. This study sought: to describe
coronary disease morbidity and mortality across 5 years of
follow-up in a cohort of persons attended in a primary-
care setting; and to analyse the association between such
morbidity and mortality, and subjects' serum cholesterol
levels, blood pressure, glucaemia, tobacco use and over-
weight.
Methods
Eight primary-care centres in the Province of Zaragoza
participated in the study, each contributing to the consti-
tution of the cohort with the entire population assigned
by the Spanish National Health Service to each of the par-
ticipating doctors. In May 1994, a closed cohort of 6262
men and women over the age of 25 years was thus formed.
The patients were base-line interviewed and explored after
obtaining their informed consent, at the time of request-
ing some type of service, regardless of the reason for their
medical visits. All patients who presented with history of
ischaemic heart disease or cerebrovascular accident were
excluded. Patients were subsequently followed up on a
consultation-on-demand basis until May 1999; during
this 5 year period all episodes of fatal and non-fatal
ischaemic heart disease were systematically searched and
duly registered. On conclusion of the study, all patients
who had not attended the primary-care centre in the pre-BMC Public Health 2006, 6:38 http://www.biomedcentral.com/1471-2458/6/38
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ceding 9 months were contacted by telephone to identify
any possible non-reported events.
An ischaemic cardiac event (codes 410 to 414, Ninth Revi-
sion of the International Classification of Diseases: ICD-
9) was defined as any event diagnosed as acute myocardial
infarction, non-Q wave myocardial infarction, unstable
angina, angina or coronary angioplasty by the cardiolo-
gists' or reference hospitals' reports, or death certificates in
the case of sudden deaths. From these, only those cases
that fulfilled MONICA diagnostic criteria were classified
as AMI (definite or probable). No attempt was made to
recode cases according to the new definition of acute cor-
onary syndromes, because the information that would
have been needed to do so was not gathered at the time
the study was conducted. All events were validated against
clinical records. For this study only incident first-ever
events were considered; in case of multiple or recurrent
events only the first one was considered.
A total of 138 individuals (2.2%) who could not be fol-
lowed up after enrolment, were deemed to be lost to fol-
low-up. Consequently, the final cohort numbered 6124
persons (3393 women and 2731 men).
At baseline (date of enrolment) and across follow-up, the
following information was collected on each patient: sex,
age, smoking habit, systolic and diastolic blood pressure,
weight and height, total cholesterol, high-density lipopro-
tein cholesterol (HDL-c), low-density lipoprotein choles-
terol (LDL-c), triglyceride and glucose. To standardise the
recording of data, the eight researchers used the
"HIPÓCRATES" clinical-history-management software
programme as supplied by the Spanish General Medicine
Society (SEMG).
Biochemical methods were those routinely used in Span-
ish primary-care system. Blood was extracted after a 10–12
hour fast. Extracted specimens were immediately refriger-
ated and stored until delivery that same day to the labora-
tory. Total cholesterol and HDL-cholesterol
concentrations were determined by the cholesterol oxi-
dase: p-aminophenazone (CHOD-PAP) method (enzy-
matic colorimetric test), after separation by precipitation
and centrifugation of kilomicrons, VLDL and LDL. LDL
concentration was calculated using Friedewald's formula
[19]. Determination of glucaemia was performed using
the hexokinase-based GLUCO-QUANT method.
Blood pressure was measured twice with the subject
seated and at rest, using a mercury sphygmomanometer,
as per the Hypertension Detection and Follow-up Pro-
gram Guidelines [20]. Smoking habit was evaluated by
interviewing subjects as to their present and past history of
tobacco use. Condition of previous ischaemic event was
likewise assessed. We defined: a smoker as any individual
who had regularly smoked a minimum of 1 cigarette per
day up to two years prior to the study termination date;
and a non-smoker as any patient that had never regularly
smoked 1 or more cigarettes per day, or had done so more
than 2 years prior to the study termination date.
Statistical analysis
Frequency of coronary events and coronary and all-cause
mortality were calculated by means of incidence and mor-
tality rates per person-years of observation, with the fol-
low-up period defined as the time elapsed from the start
of the study to the date of appearance of the event or
death, where applicable, or alternatively, from the start of
the study to the study termination date (May 1999); in the
case of mortality rates, the time was deemed to run until
the date of death or termination of the study. Rates were
adjusted for age, taking the age distribution of the Stand-
ard European population as reference.
Survival analysis was used to describe and analyse the
experience of coronary morbidity in the cohort, with the
Kaplan-Meier method for the univariate analyses and Cox
proportional risk regression for the multivariate analysis.
In both cases, the association between IHD-free survival
and cardiovascular risk factors was evaluated in accord-
ance with pre-established dichotomous categories of risk
factors. For each such factor (systolic and diastolic blood
pressure, total cholesterol, LDL- and HDL-cholesterol,
glucaemia, weight), we took the mean value of the
repeated measures obtained across follow-up. The crite-
rion used to define arterial hypertension (AHT) was the
Sixth Report of the Joint National Committee, which
defined hypertension as systolic blood pressure (SBP) ≥
140 mm Hg and/or diastolic blood pressure (DBP) ≥ 90
mm Hg [21]. Hypercholesterolaemia was defined as total
cholesterol ≥ 240 mg/dl as per NCEP (ATP II) criteria [22].
The effect of the LDL and HDL lipoprotein level was
jointly assessed by reference to the atherogenic index
(LDL/HDL ratio); for the purpose of this index, a cut-off
of 3 was used to define the categories. The diagnostic cri-
terion for definition of diabetes mellitus was fasting
plasma glucose ≥ 126 mg/dl, as per the ADA recommen-
dations [23]. Overweight was defined as a Body Mass
Index (BMI; weight, expressed in kilograms, divided by
the square of the height, expressed in metres) > = 25.
Treated patients were classified as exposed when the mean
of the repeated measures was above the cut-off values; this
way, not controlled patients remained as exposed and
controlled patients were classified either as exposed or not
exposed depending on the degree of effective control.
To avoid overadjustment, overweight was excluded from
the Cox model in assessing the effect of diabetes and AHT,
and LDL/HDL ratio in measurement of the effect of hyper-BMC Public Health 2006, 6:38 http://www.biomedcentral.com/1471-2458/6/38
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cholesterolemia, since they share the etiological pathway.
To avoid potential bias and power shortages due to dele-
tion of cases in complete-case analysis, missing data in
covariates were replaced by multiple imputation, with
age, sex and coronary disease outcome taken as predictors
[24]. If missing data in a variable were more than 30%,
these were not imputed and the variable considered as
measured only in a subgroup of the cohort. This occurred
in BMI and LDL/HDL ratio variables.
The study complies with the World Medical Association
Declaration of Helsinki. Due to the non-experimental
nature of the research, the study protocol did not need to
be submitted for consideration and approval to an ethical
review committee.
Results
The general characteristics of the cohort, comprising 6124
patients (44.6% men, 55.4% women) are described in
Table 1. A more detailed description has been previously
published [25]. The age range was 25–99 years (mean ±
standard deviation 50.4 ± 15 and 52.8 ± 16 in men and
women respectively, p = 0.000), with 24% of patients
being over 65 and 9% over 75 years of age. The prevalence
of the cardiovascular risk factors considered was as fol-
lows: 34% of men and 13% of women were current smok-
ers (p = 0.00); 76% and 73% respectively were overweight
(p = 0.02); and 33 and 37% respectively were hypercho-
lesterolaemic (p = 0.03). Frequency of arterial hyperten-
sion (38% in men, 36% in women) and diabetes mellitus
(11%) showed no statistically significant differences
between the sexes.
The age and gender distributions of the study cohort vis-
à-vis those of the Zaragoza general population obtained
from official demographic statistics are depicted in Figure
1. These distributions in the study population overlaps
that of the general population, with the differences of
female (55% vs. 52%) and the 35–64 age group (56% vs.
52%) being slightly over represented in the cohort.
Over the 5 years of study, the 6124 patients included in
the cohort furnished 30,386 person-years of observation
(mean ± standard deviation 4.96 ± 0.03 years), with 159
patients (0.02%) with incomplete follow-up due to com-
peting mortality. A hundred and fifty-five first episodes of
all forms of ischaemic heart disease were detected (fatal
and non-fatal) (Table 2). The crude incidence rates per
100,000 person-years were 650 in men and 403 in
women; the age-adjusted rates remained higher for men
Table 1: General characteristics of the cohort compared to general population.
Cohort (%) General population *(%)
Age
25–29 9 11
30–34 10 11
35–39 8 10
40–44 9 9
45–49 11 9
50–54 9 8
55–59 8 7
60–64 11 9
65–69 9 8
70–74 7 7
75–79 4 5
80–84 3 3
85 and over 2 3
Gender
Male 45 48
Female 55 52
Vascular risk factors Male Female Male Female
Current smoking 34 13 40,7 (37–44) 24,1 (21–26)
Serum total cholesterol >= 
240 mg/dl
33 37 27,3 (17–37) 23,4 (16–31)
Arterial pressure >= 140/
90 mmHg
38 36 35,6 (27–44) 31,8 (24–39)
Glucose > = 126 mg/dl 11 11 12,5 (11–14) 7,9 (7–9)
Body mass index>= 25 76 73 66,9 (63–71) 48,3 (41–55)
* Age and sex distribution in general population (province of Zaragoza) obtained from census data. Prevalence and 95% confidence interval (in 
brackets) of vascular risk factors in Spanish general population obtained from reference 9.BMC Public Health 2006, 6:38 http://www.biomedcentral.com/1471-2458/6/38
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Age and gender distribution of the study population and of the Zaragoza general population Figure 1
Age and gender distribution of the study population and of the Zaragoza general population.
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than for women, with figures of 362 and 191 new cases
per 100,000 person-years respectively, and increased with
age in both sexes. This incidence pattern -namely, increas-
ing with age, and higher in men than in women- was
maintained for acute myocardial infarction alone.
Twenty-one of the 155 episodes of ischaemic heart disease
resulted in death, yielding an age-adjusted IHD mortality
rate of 42.5 and 25.8 per 100,000 person-years, for men
and women respectively (Table 2). All-cause mortality in
this cohort was 5.92 per 1000 person-years (adjusted rate
of 3.15 per 1000).
All the risk factors considered displayed an statistically sig-
nificant association with incidence of ischaemic heart dis-
ease in the univariate analysis (Figure 2, table 3), the
strongest associations being observed for age and over-
weight. After multivariate adjustments, age, male gender,
Table 2: Incidence and mortality due to Ischaemic Heart Disease (IHD) and Acute Myocardial Infarction (AMI).
Age in years n Person-
years
No. IHD 
events
IHD 
Incidence rate 
× 
105person-years
No. AMI 
events
AMI 
Incidence rate 
× 
105person-years
No. IHD 
deaths
IHD 
Mortality rate 
× 
105person-years
MEN
25–29 272 1,377.6 1 72.6 1 72.6 0 0.0
30–34 295 1,491.1 1 67.1 1 67.1 0 0.0
35–39 225 1,138.7 1 87.8 1 87.8 0 0.0
40–44 241 1,218.6 1 82.1 1 82.1 0 0.0
45–49 321 1,614.2 5 309.7 1 61.9 0 0.0
50–54 266 1,321.3 8 605.5 2 151.4 0 0.0
55–59 238 1,163.0 13 1,117.8 9 773.9 1 86.0
60–64 286 1,402.8 14 998.0 4 285.2 1 71.3
65–69 242 1,153.7 20 1,733.6 12 1,040.2 5 433.4
70–74 186 880.8 14 1,589.5 7 794.7 0 0.0
75–79 80 394.1 4 1,015.0 2 507.5 1 253.7
80–84 57 264.6 6 2,267.4 4 1,511.6 3 1,133.7
85 and over 22 108.8 0 0.0 0 0.0 0 0.0
25 and over (crude) 2,731 13,529.2 88 650.4 45 332.6 11 81.3
25 and over (adjusted) 362.7 188.0 42.5
25–74 (adjusted) 2,572 12,761.7 78 366.7 39 183.4 7 32.9
35–64 (adjusted) 1,872 9,349.7 43 211.6 19 93.5 2 9.8
WOMEN
25–29 293 1,485.4 0 0.0 0 0.0 0 0.0
30–34 311 1,576.6 0 0.0 0 0.0 0 0.0
35–39 271 1,373.8 0 0.0 0 0.0 0 0.0
40–44 283 1,434.7 0 0.0 0 0.0 0 0.0
45–49 360 1,815.6 2 110.2 0 0.0 0 0.0
50–54 304 1,533.1 2 130.5 2 130.5 0 0.0
55–59 276 1,375.6 7 508.9 2 145.4 0 0.0
60–64 362 1,801.8 8 444.0 1 55.5 0 0.0
65–69 314 1,506.6 17 1,194.7 7 464.6 3 199.1
70–74 266 1,314.1 8 608.8 0 0.0 0 0.0
75–79 172 806.1 13 1,612.7 3 372.2 3 372.2
80–84 114 534.9 7 1,308.8 3 560.9 2 373.9
85 and over 67 299.3 3 1,002.2 3 1,002.2 2 668.2
25 and over (crude) 3,393 16,857.5 67 403.4 21 124.6 10 59.3
25 and over (adjusted) 191.0 62.3 25.8
25–74 (adjusted 3,040 15,217.2 45 177.4 12 47.3 3 11.8
35–64 (adjusted) 2,167 10,911.2 19 80.1 5 21.1 0 0BMC Public Health 2006, 6:38 http://www.biomedcentral.com/1471-2458/6/38
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Ischaemic heart disease-free survival by category of vascular risk factors Figure 2
Ischaemic heart disease-free survival by category of vascular risk factors.
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Table 3: Ischaemic heart disease incidence by category of exposure to cardiovascular risk factors.
BOTH SEXES MEN WOMEN
No. 
patients
No. 
events
Cumulative 
incidence rate 
(%)
pN o .  
patients
No. 
events
Cumulative 
incidence rate 
(%)
pN o .  
patients
No. 
events
Cumulative 
incidence rate 
(%)
p
AGE <65 4,671 64 1.4 2,169 44 2.0 2,502 20 0.8
>= 65 1,453 91 6.3 <0.001 562 44 7.8 <0.001 891 47 5.3 <0.001
CURRENT SMOKING No 3,361 90 2.7 1,230 38 3.1 2,131 52 2.4
Yes 959 44 4.6 0.002 642 39 6.1 0.003 317 5 1.6 0.380
LDL/HDL RATIO <3 1,781 43 2.4 572 21 3.7 1,209 22 1.8
> = 3 1,615 95 5.9 <0.001 884 59 6.7 0.016 731 36 4.9 <0.001
SERUM TOTAL 
CHOLESTEROL (mg/dl)
<240 2,793 81 2.9 1,207 49 4.1 1,586 32 2.0
> = 240 1,513 67 4.4 0.008 597 35 5.9 0.091 916 32 3.5 0.022
ARTERIAL PRESSURE 
(mmHg)
<140/90 2,818 81 2.9 1,161 45 3.9 1,657 36 2.2
> = 140/90 1,655 69 4.2 0.019 723 41 5.7 0.086 932 28 3.0 0.188
GLUCOSE (mg/dl) <126 3,940 118 3.0 1,635 73 4.5 2,305 45 2.0
> = 126 494 29 5.9 0.001 215 11 5.1 0.666 279 18 6.5 <0.001
BODY MASS INDEX <25 857 15 1.8 327 8 2.4 530 7 1.3
> = 25 2,468 117 4.7 <0.001 1,054 66 6.3 0.007 1,414 51 3.6 0.008BMC Public Health 2006, 6:38 http://www.biomedcentral.com/1471-2458/6/38
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smoking habit, hypercholesterolaemia and the LDL/HDL
ratio remained strongly and consistently associated with
risk of suffering ischaemic heart disease after five years of
follow-up (Table 4). The positive, significant effect of age,
as well as those of cholesterol, LDL/HDL ratio and BMI on
risk remained significant when they were taken in a con-
tinuous scale. The presence of hypertension, that showed
a 24% increase in risk that did not reach statistical signif-
icance in the analysis for the hole cohort, was statistically
associated with disease in men but not in women. Positive
and high relative risks for overweight an smoking in
women were almost statistically significant. Lastly, diabe-
tes proved to be associated with disease in women but not
in men.
There were only three cases of sudden death, two of them
presenting symptoms of severe neurological deficit and
no chest pain. These contributed to follow up time until
the date of death, which was recorded as due to probable
stroke.
The one single case of sudden death with AMI compatible
symptoms was considered as probable AMI, following
MONICA criteria. The inclusion or exclusion of this case
of the analysis did not modify the results.
Discussion
Knowledge of the magnitude of IHD risk, along with iden-
tification of the factors responsible and populations at
greatest risk, are fundamental for the planning and assess-
ment of preventive and health-care strategies and identifi-
cation of specific excess-risk scenarios. There is a dearth of
such information in Spain. This study sought to describe
the epidemiology of ischaemic heart disease and acute
myocardial infarction in a cohort drawn from the popula-
tion attending primary-care centres.
Epidemiological studies conducted in a primary care set-
ting can be subject to several limitations, that must be
taken into account [26]. Firstly, this cohort cannot be
regarded as representative of the general population but
only of those who use primary-care services, although it
should be stressed that the Spanish National Health Serv-
ice covers the entire population and that, according to the
Spanish National Health Survey, 80% of the Spanish
adult population attends such health centres at least once
a year [27]. In this study, the age and sex distribution of
the cohort was very similar to that of the general popula-
tion, but substantial differences in frequentation to pri-
mary care by age and sex have been well described in
many studies, so it is likely that detection and exposure
classification biases could be present; to minimize this
potential biases the study protocol included systematic
search of events and exposures during follow-up and at
the end of the study period. This systematic approach
explains the very low percentage of patients lost for fol-
low-up. Anyway, we must further remark that the study
population is not a random sample of general population,
so any generalization of the results should be cautious.
Furthermore, the cohort is not a sample but the entire
population covered by the participant health centres but
these were not randomly sampled, this meaning that the
results are applicable only to the study population, and of
course this population is not representative of other pop-
ulations.
Clinical trials have demonstrated that effective medical
control of vascular risk factors reduces risk, so classifying
treated patients as exposed (as has traditionally been
done) could have biased the results, mostly when the
study was conducted in a medical setting. In the same
manner, including treated patients as not exposed would
have also introduce a bias because effective control is not
always achieved. This potential exposure misclassification
derived from medical treatment and control has been
approached by taking the mean of repeated measures for
arterial pressure, serum cholesterol and glucose, so treated
patients were therefore classified as exposed when the
mean of the repeated measures was above the cut-off val-
ues; this way, not controlled patients remained as exposed
and controlled patients were classified either as exposed /
not exposed depending on the degree of effective control.
In the same way, multiple imputation of missing data was
used to prevent biases derived from the aggregation of
missing data in different variables when considering them
jointly in multivariate analyses [24].
The age-adjusted acute myocardial infarction incidence
rates registered in this study are similar to those of the
IBERICA study for the general population registers of 7
Spanish regions as a whole, the MONICA-Catalonia, the
REGICOR and the IBERICA-Murcia studies [2,4,5,28].
Nevertheless, it should be borne in mind here that our
study targeted an older population, i.e., whereas in the
above studies the study population was aged 25–75 years,
in our cohort 10% of women and 5% of men were over 75
years old. Still, when this age breakdown was taken into
account, the incidence rates in our cohort were almost the
same as those found in the general population, despite the
fact that this was a medical-settled study. The likelihood
of information on events in the cohort being lost is prac-
tically non-existent, since the researchers were the desig-
nated general practitioners of the patients enrolled, and
therefore responsible for their medical follow-up and pre-
scription of drugs in the case of cardiovascular episodes.
At all events, on termination of the study all patients who
had not attended the primary-care centre in the preceding
9 months were contacted by telephone.BMC Public Health 2006, 6:38 http://www.biomedcentral.com/1471-2458/6/38
Page 10 of 11
(page number not for citation purposes)
In Spain, only two other cohort studies have been con-
ducted to date, aimed at measuring and analysing the risk
of IHD, namely the Manresa and DRECE studies, though
their results are not entirely comparable vis-à-vis our
study or even each other, due to differences in methodol-
ogy and design [6,7]. Taking the above limitations on
comparability into account, it can be concluded that the
incidence rates registered in the present study do not
diverge from those published in Spain until now, and that
any differences are attributable to design. This incidence is
very high compared to Spanish incidence rates for other
chronic diseases, and indeed exceeds the joint incidence
of colon, rectal, lung and breast cancer combined [29]. In
the international context, the myocardial infarction inci-
dence rate in this population is very low compared to
those reported for non-Spanish populations in the MON-
ICA study [2] and under-65 mortality is lower than that
reported in cohorts included in the SCORE project,
though these cohorts were studied 20–30 years ago [15].
IHD incidence in this cohort should be interpreted in the
light of its level of cardiovascular risk. Compared to the
general Spanish population, this cohort registered compa-
rable prevalences of arterial hypertension and diabetes,
slightly higher prevalences of overweight and hypercho-
lesterolaemia, and a lower prevalence of tobacco use. The
differences in risk profile in studies targeting persons
attending primary-care centres is known and has been pre-
viously reported [9]. However, with the sole exception of
the low frequency of smoking (34% and 13% among men
and women respectively versus 40% and 25% in the gen-
eral population), the differences in this study are not
unduly pronounced, something that would lead one to
expect IHD incidence rates to be within the range of those
reported by population-based studies in Spain, as is
indeed the case.
Analysis of the association between cardiovascular risk
factors and risk of ischaemic heart disease yields results in
line with what was expected, with age, smoking, elevated
LDL-cholesterol, hypertension, diabetes and overweight
emerging as linked to the risk of suffering an event. This is
the first ever cohort study in Spain to show these associa-
tions, since previous studies were unable to rule out the
null hypothesis for overweight, dyslipaemia or diabetes
[6,7]. Insofar as arterial hypertension is concerned, the
absence of statistical significance in the association
among women may be reflecting a better medical control
of AHT than among men. Information on treatment and
effective control of AHT was not collected in this study,
and we believe that further research is needed to identify
possible gender differences in AHT awareness, treatment
and control in Spain.
Lastly, this study shows the feasibility of conducting epi-
demiological studies in primary-care settings. Further-
more, the opportunities offered by the primary health care
setting were not utilised fully in this study, i.e. treatment
information was not recorded when it would have been
feasible and desirable. Particular strenghths were found,
as the minimization of follow-up and event losses or diag-
nostic misclassifications. Potential weaknesses, as selec-
tion biases due to demographic differences of primary-
care frecuentation can been also minimized by an ade-
quate, systematic approach. This systematic approach
should also be used to prevent the miss of data, a possibil-
ity always present in large cohort studies, moreover with
the high work load of primary-care doctors.
Conclusion
To sum up, IHD incidence and mortality rates were lower
than those reported for other countries and other periods,
despite a high prevalence of cardiovascular risk factors,
thus confirming similar results reported in other cohort
and population-based studies in Spain. Effect measures of
vascular risk factors were mainly as reported worldwide
and support the hypothesis that protective factors not
considered in this study must exist as to explain low rates.
Table 4: Multivariate adjusted effect of cardiovascular risk factors on incidence of ischaemic heart disease.
BOTH SEXES MEN WOMEN
RR IC 95% p RR IC 95% p RR IC 95% p
MALE GENDER 1.65 1.16 2.34 .005 - - - - - - - -
AGE >= 65 4.93 3.45 7.06 <0.001 4.04 2.54 6.40 <0.001 6.71 3.72 12.09 <0.001
CURRENT SMOKING 2.60 1.75 3.85 <0.001 2.72 1.73 4.26 <0.001 2.03 .77 5.32 .151
CHOLESTEROL >= 240 1.97 1.42 2.73 <0.001 1.95 1.26 3.00 .003 1.92 1.17 3.14 .010
SBP/DBP >= 140/90 1.24 .88 1.73 .218 1.61 1.04 2.50 .033 .80 .47 1.36 .412
GLUCOSE >= 126 1.52 1.00 2.33 .050 .92 .47 1.78 .798 2.51 1.41 4.45 .002
BMI > = 25 2.21 1.28 3.83 .004 2.31 1.10 4.86 .027 2.03 .90 4.59 .089
LDL/HDL RATIO >= 3 2.12 1.40 3.20 <0.001 1.80 1.02 3.16 .042 2.43 1.34 4.40 .003BMC Public Health 2006, 6:38 http://www.biomedcentral.com/1471-2458/6/38
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